Validation Study of Non-Invasive Blood Pressure

Overview

Información sobre este estudio

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial arterial line (A-line) in critical care patients.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Patient admitted into the NICU, PICU, or ICU.
  • Adult aged 18 years and older, or parent/legal guardian of minor, willing and able to understand and provide informed consent/assent in English language.
  • Indication for NIBP cuff.
  • Indication for radial arterial line.
  • Meet the following stratification criteria across the study:
    • Stratification:
      • Subject Group 1:
        • At least 3 patients shall be 2000 g in weight;
        • At least 3 patients shall be ≥ 29 days and < 1 year of age;
        • At least 3 patients shall be ≥ 1 year and < 3 years of age;
        • The remaining patients may be from any of the above age or weight groups in order to complete the sample size;
        • A patient can be in more than one category simultaneously.
      • Subject Group 2 and 3:
        • At least 30% male, 30% female;
        • At least 1/8 of total adolescent/adult ≥ 5 years of age needs to be tested with each cuff size (4 cuff sizes total);
        • at least 40 % of the subjects shall have a limb circumference that lies within the upper half of the specified range of use of the cuff; and
        • at least 40 % shall have a limb circumference within the lower half of the specified range of use.
      • Subject Group 3:
        • At least 10% SBP ≤ 100mmHg;
        • At least 10% SBP ≥ 160mmHg;
        • At least 10% DBP ≤ 70mmHg;
        • At least 10% DBP ≥ 85mmHg.

Exclusion Critieria:

  • Inability to place the study device appropriately due to patient’s anatomy or condition.
  • Known pregnancy or lactating women (self-report).
  • Patients treated with an intra-aortic balloon pump.
  • Aortic and mitral regurgitation (> 2nd degree).
  • Measurements taken in the lateral position.
  • Currently participating in another clinical trial with any product, treatment and/or medication that clinically interferes with the study endpoint(s).
  • If valid SBP reference measurements for lateral difference is > 15 mmHg.
  • If valid DBP reference measurements for lateral difference is > 10 mmHg.
  • At the Principal Investigator’s discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above.

Eligibility last updated 9/7/22. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Devang Sanghavi, M.B.B.S., M.D.

Cerrado para la inscripción

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publicaciones

Publications are currently not available
.
CLS-20543631

Mayo Clinic Footer